The Archive · 3 posts
Decode disease with Verici Dx (VRCI) 🔬. A innovator in renal diagnostics, shaping the future of healthcare. Dive in to discover more! 🚀
Verici Dx reports FY25 commercial progress: Tutivia tests up 250% to 1,173, Medicare coverage secured, but cash burn remains key risk.
June 29, 2026
Showing 2 of 3 posts
Verici Dx Q1 2026: Tutivia testing volumes jump 32% as adoption widens across US transplant centres and reimbursement tailwinds build. A strong start to the year.
JoshuaApril 16, 2026
Verici Dx's FY25 growth driven by first Tutivia revenues and key Medicare coverage, unlocking scalable commercial expansion.
JoshuaFebruary 5, 2026